To explore the anion recognition ability of silanol hydroxy groups, a silanediol-based receptor 1 was prepared. Spectroscopic studies and X-ray crystallography revealed that the receptor exhibits the
Global Insulin Biosimilars Market size was valued at USD 2.67 billion in 2022 and is poised to grow from USD 2.80 billion in 2023 to USD 4.07 billion by 2031, growing at a CAGR of 4.8% in the forecast
G protein–coupled receptors (GPCRs) signal through a limited number of G-protein pathways and play crucial roles in many biological processes. Studies of their in vivo functions have been hampered by
Insulin Biosimilars Market is segmented By Biosimilar Type (Rapid-acting Biosimilars, Long-acting Biosimilars, and Premixed Biosimilars) and Disease Indication Type (Type 1 Diabetes and Type 2 Diabete
Multifunctional ligands with agonist bioactivities at μ/δ opioid receptors (MOR/DOR) and antagonist bioactivity at the neurokinin-1 receptor (NK1R) have been designed and synthesized. These peptide-ba
